Dizal seeks FDA approval for NSCLC treatment sunvozertinib
Dizal has submitted sunvozertinib’s new drug application (NDA) to the US Food and Drug Administration (FDA) aiming to secure approval for treating locally advanced or metastatic non-small cell lung ...
BioSpace7hOpinion
Opinion: Drugs Are Becoming ‘smarter.’ Here’s How
I have long held the belief that digital therapeutics will be prescribed alongside drugs to improve patient outcomes, leading ...
Alembic Pharmaceuticals receives USFDA approval for Diltiazem Hydrochloride ER capsules
Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem ...